Companies › BCRX

BIOCRYST PHARMACEUTICALS INC (BCRX)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0000882796 · EDGAR filings · Updated 2026-06-29

BIOCRYST PHARMACEUTICALS INC (BCRX) has reported institutional ownership of 97.4%, with 299 institutional managers holding positions valued at $2.36B per the latest 13F reporting period.

Latest updates

• 2026-06-29 — Current report (8-K) filed
• 2026-06-15 — Insider transaction reported (Form 4)
• 2026-06-15 — Insider transaction reported (Form 4)
• 2026-06-15 — Insider transaction reported (Form 4)
• 2026-06-15 — Insider transaction reported (Form 4)
• 2026-06-15 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, BIOCRYST PHARMACEUTICALS INC has 299 institutional holders and institutional ownership of 97.4%.

Insider activity

Insiders reported 57 transactions (0 buys, 9 sells) across 15 reporting insiders, with a net reported value of −$4.03M.

Related companies

ENLIVEN THERAPEUTICS INC (ELVN) · VIKING THERAPEUTICS INC (VKTX) · LEMAITRE VASCULAR INC (LMAT) · LIFESTANCE HEALTH GROUP INC (LFST) · SYNDAX PHARMACEUTICALS INC (SNDX) · LIQUIDIA CORPORATION COM NEW (LQDA)